Detected ·

SonoThera

$125M—

SonoThera raised $125M in Series B led by Vida Ventures, with participation from Leaps by Bayer, Otsuka Pharmaceutical, UCB Ventures, and Johnson & Johnson Innovation – JJDC. The company uses ultrasound and microbubbles to deliver genetic medicines non-virally, targeting DMD and polycystic kidney disease with a first-in-human trial planned for 2027.

Amount
$125 000 000 USD
Stage
—
Event
Funding round
Detected
2026-06-25 08:07:24 UTC
Signal ID
02f9991e-6208-43f5-90d0-634f3f75e494

As the API returns it

{
  "id": "02f9991e-6208-43f5-90d0-634f3f75e494",
  "created_at": "2026-06-25T08:07:24.186646Z",
  "company_name": "SonoThera",
  "company_website_url": "sonothera.com",
  "company_linkedin_url": "https://www.linkedin.com/company/sonothera",
  "event_type": "funding",
  "funding_amount": 125000000,
  "funding_currency": "USD",
  "funding_stage": null,
  "message": "*SonoThera raised $125M in Series B led by Vida Ventures, with participation from Leaps by Bayer, Otsuka Pharmaceutical, UCB Ventures, and Johnson & Johnson Innovation – JJDC. The company uses ultrasound and microbubbles to deliver genetic medicines non-virally, targeting DMD and polycystic kidney disease with a first-in-human trial planned for 2027.*"
}

Latest rounds